Search

Karl G Wassmann

from South Portland, ME
Age ~40
Get Report
Also known as:
Karl G Wassman
Related to:
Andrew T Desrosiers, 33Toby N Christensen, 50David E Smyth, 54
Connected to:
Jerry W Wassmann, 79Bonnie L Wassmer, 65Christopher Wassmer, 36Kathryn M Wassmer, 43Lynn Wassmer, 65Marc Wassmer, 62Randi K Wassmer, 60Shauna M Wassmer, 35Glen R Wassmuth, 70James R Wassmuth, 44

Karl Wassmann Phones & Addresses

  • South Portland, ME
  • 14 Pond St, Dover, MA 02030 (508) 785-0623 (508) 785-1893

Business Records

Name / Title
Company / Classification
Phones & Addresses
Karl Wassmann
Owner
Karl G Wassmann Consultin
Business Consulting Services
14 Pond St, Dover, MA 02030
Karl G. Wassmann
President
KARL G. WASSMANN CONSULTING, INC
40 Grv St, Wellesley, MA 02181
Karl Wassmann
Treasurer
Valuation Perspectives Inc
Biotechnology
40 Grv St, Wellesley, MA 02482
14 Pond St, Dover, MA 02030

Publications

Us Patents

Gene Expression Profiling For Identification Monitoring And Treatment Of Rheumatoid Arthritis

View page
US Patent:
20070196835, Aug 23, 2007
Filed:
Sep 27, 2006
Appl. No.:
11/529010
Inventors:
Kathy Storm - Longmont CO, US
Lisa Siconolfi - Westminster CO, US
David Trollinger - Boulder CO, US
Karl Wassmann - Dover MA, US
International Classification:
C12Q 1/68
G06F 19/00
US Classification:
435006000, 702020000
Abstract:
A method is provided in various embodiments for determining a profile data set for a subject with rheumatoid arthritis or inflammatory conditions related to rheumatoid arthritis based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 2 constituents from Tables 1-2 and Tables 4-10. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.

Gene Expression Profiling For Identification, Monitoring And Treatment Of Multiple Sclerosis

View page
US Patent:
20080070243, Mar 20, 2008
Filed:
Jun 16, 2006
Appl. No.:
11/454553
Inventors:
Michael Bevilacqua - Boulder CO, US
Victor Tryon - Woodinville WA, US
Lisa Siconolfi - Westminster CO, US
David B. Trollinger - Boulder CO, US
Karl Wassmann - Dover MA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides methods of characterizing multiple sclerosis pr inflammatory conditions associated with multiple sclerosis using gene expression profiling.

Gene Expression Profiling For Identification, Monitoring And Treatment Of Multiple Sclerosis

View page
US Patent:
20080183395, Jul 31, 2008
Filed:
Jul 13, 2007
Appl. No.:
11/827892
Inventors:
Michael Bevilacqua - Boulder CO, US
Victor Tryon - Woodinville WA, US
Lisa Siconolfi - Westminster CO, US
David B. Trollinger - Boulder CO, US
Karl Wassmann - Dover MA, US
International Classification:
C12Q 1/68
G01N 33/48
US Classification:
702 19, 435 6
Abstract:
The present invention provides methods of characterizing multiple sclerosis or inflammatory conditions associated with multiple sclerosis using gene expression profiling.

Assessment Of Effect Of An Agent On A Human Biological Condition Using Rodent Gene Expression Panels

View page
US Patent:
20080227655, Sep 18, 2008
Filed:
May 16, 2007
Appl. No.:
11/804175
Inventors:
Michael Bevilacqua - Boulder CO, US
Victor Tryon - Woodinville WA, US
John Cheronis - Conifer CO, US
Kathleen Storm - Longmont CO, US
Karl Wassmann - Dover MA, US
International Classification:
C40B 30/06
C40B 40/08
US Classification:
506 10, 506 17
Abstract:
Rodent gene expression data, in particular, gene expression profiles, are created and used to predict the efficacy of therapeutic agents on human biological conditions. Gene Profile data sets are derived from rodent subject samples and include quantitative, substantially repeatable measures of a distinct amount of RNA or protein constituent(s) in a signature panel selected such that measurement of the constituent(s) enables measurement of a biological condition of interest in both human and rodent subjects. Such profile data sets may be used to predict the therapeutic efficacy of a therapeutic agent in humans.

Gene Expression Profiling For Identification, Monitoring And Treatment Of Lung Cancer

View page
US Patent:
20100184034, Jul 22, 2010
Filed:
Nov 6, 2007
Appl. No.:
12/514686
Inventors:
Kathleen Storm - Longmont CO, US
Karl Wassmann - Dover MA, US
Lisa Siconolfi - Westminster CO, US
Assignee:
SOURCE PRECISION MEDICINE, INC d/b/a SOURCE MDX - BOULDER CO
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
A method is provided in various embodiments for determining a profile data set for a subject with lung cancer or conditions related to lung cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-5. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that arc substantially repeatable.

Gene Expression Profiling For Identification, Monitoring And Treatment Of Colorectal Cancer

View page
US Patent:
20100196889, Aug 5, 2010
Filed:
Nov 13, 2006
Appl. No.:
12/514775
Inventors:
Lisa Siconolfi - Westminster CO, US
Kathleen Storm - Longmont CO, US
Karl Wassmann - Dover MA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
A method is provided in various embodiments for determining a profile data set for a subject with colorectal cancer or conditions related to colorectal cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-5. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.

Gene Expression Profiling For Identification, Monitoring, And Treatment Of Ocular Disease

View page
US Patent:
20100209915, Aug 19, 2010
Filed:
Dec 18, 2007
Appl. No.:
12/520675
Inventors:
Lisa Siconolfi - Westminster CO, US
Kathleen Storm - Longmont CO, US
Karl Wassmann - Dover MA, US
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
A method is provided in various embodiments for determining a profile data set for a subject with ocular disease or conditions related to ocular disease based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least one constituent from Tables 1-5, 7-9, and 11-13. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.

Gene Expression Profiling For Identification, Monitoring And Treatment Of Ovarian Cancer

View page
US Patent:
20100216137, Aug 26, 2010
Filed:
Nov 6, 2007
Appl. No.:
12/594675
Inventors:
Lisa Siconolfi - Westminster CO, US
Kathleen Storm - Longmont CO, US
Karl Wassmann - Dover MA, US
Assignee:
Source Precision Medicine, Inc d/b/a Source MDX - Boulder CO
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
A method is provided in various embodiments for determining a profile data set for a subject with ovarian cancer or conditions related to ovarian cancer based on a sample from the subject, wherein the sample provides a source of RNAs. The method includes using amplification for measuring the amount of RNA corresponding to at least 1 constituent from Tables 1-5. The profile data set comprises the measure of each constituent, and amplification is performed under measurement conditions that are substantially repeatable.
Control profile
Karl G Wassmann from South Portland, ME, age ~40 Get Report